Hypoparathyroidism, Bone, and Mineral Metabolism


Hypocitraturia Is an Untoward Side Effect of Human Parathyroid Hormone (hPTH) 1-34 Therapy in Hypoparathyroidism That May Increase Renal Calcifications
Rachel I Gafni, Craig B Langman, Lori C. Guthrie, Beth Brillante, Robert James, Nancy A Yovetich, Alison M Boyce and Michael T. Collins


Recombinant Human Parathyroid Hormone, (rhPTH[1-84], Parathyroid Hormone rDNA) Improves Hypercalciuria in Patients with Hypoparathyroidism: 3-Year Analysis from Race Study
Tamara J. Vokes, John P. Bilezikian, Henry G. Bone III, Bart Lyman Clarke, Douglas S. Denham, Hak-Myung Lee, Michael A. Levine, Michael Mannstadt, Munro Peacock, Jeffrey G. Rothman, Dolores M. Shoback, Mark Lowe Warren, Nelson B. Watts and Alan Krasner


Continuous Subcutaneous PTH Infusion in Autosomal Dominant Hypocalcaemia
Evelien F Gevers, Jaccqui Buck, Neil Ashman, Rajesh V Thakker and Jeremy Allgrove


Chronic Hypoparathyroidism Disease Profile: Initial Analysis from the Paradighm™ Natural History Global Registry
Steven Wai Ing, Bart Lyman Clarke, Aliya Aziz Khan, Michael Mannstadt, Michael T. McDermott, Rebecca Piccolo, Michael Howard Shanik, Tamara J. Vokes and John Germak


Increased Bone Turnover Markers in Patients with Type 2 Diabetes Randomized to Bariatric Surgery Vs. Intensive Medical Therapy at 5 Years
Megan Crawford, Nathan Hubert Pham, Leila Zeinab Khan, James Bena, Philip Schauer and Sangeeta Rao Kashyap


Impact of Marrow Adiposity on Trabecular Microarchitecture and Strength Estimates in Adolescents with Morbid Obesity
Vibha Singhal, Fatima Cody Stanford, Alexander Toth, Charu Baskaran, Brian Carmine, Miriam A. Bredella and Madhusmita Misra